Mid-afternoon market update: Dow rises over 100 points, Itamar Medical shares spike higher fxstreet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fxstreet.com Daily Mail and Mail on Sunday newspapers.
SAN FRANCISCO, Aug. 12, 2021 /PRNewswire/ The global regenerative medicine market size is expected to reach USD 57.08 billion by 2027, growing at a CAGR of 11.27% over the forecast period
MIMEDX Announces Second Quarter 2021 Operating and Financial Results forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
ShockWave Medical, Inc. (NASDAQ: SWAV)
Verastem, Inc. (NASDAQ: VSTM)
Down In The Dumps
Akoya Biosciences, Inc. (NASDAQ: AKYA)
Decibel Therapeutics, Inc. (NASDAQ: DBTX)
IRadimed Corporation (NASDAQ: IRMD)
Lucira Health, Inc. (NASDAQ: LHDX)
Mesoblast Limited (NASDAQ: MESO)
Protara Therapeutics, Inc. (NASDAQ: TARA)
PTC Therapeutics, Inc. (NASDAQ: PTCT)
Stocks In Focus
Adverum Shares Sink On Serious Adverse Event
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) announced a suspected unexpected serious adverse reaction of hypotony, which is clinically relevant decrease in ocular pressure, in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema.
This event occurred 30 weeks after randomization in one patient treated with a single intravitreal injection of the high dose of ADVM-022 who has developed hypotony, with panuveitis and loss of vision in the treated eye.